
Transactions: Healthcare
Filter


Directed share issue in CELLINK AB (SE) — SEK 1.5 billion

Senior unsecured convertible bond issue by CELLINK AB (SE) — SEK 1.5 billion

Directed share issue in Oncopeptides AB (SE) — SEK 1,106 million

Directed share issue in Nordic Nanovector ASA (NO) — NOK 361 million

Public offer to the shareholders of Recipharm AB – SEK 25.0 billion

Directed share issue in Paxman AB (SE) — SEK 60 million

Private placement in Devyser Diagnostics AB (SE) — SEK 130 million

Rights issue in InDex Pharmaceuticals Holding AB (SE) — SEK 533 million

Private placement in Dignio AS (NO) — NOK 85 million

Acquisition of Sanos Group by Investcorp – Amount not disclosed
